NPCE logo

NeuroPace, Inc. (NPCE)

Profile

Full Name

NeuroPace, Inc.

Ticker

NASDAQ: NPCE

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

April 22, 2021

Indexes

Not included

Website

https://www.neuropace.com

Employees

195

Key Details

Price

$8.42(-1.64%)

Market cap

$278.55M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$79.91M(+22.14% YoY)

Annual EPS

-$0.93(+26.77% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.42
    NPCE price is $8.42

    30-Day Relative Volume

    1.16
    NPCE 30-day relative volume is 1.16

    Price Performance

    Price Most recent change

    -1.64%
    NPCE price was down -1.64% on Aug 18, 2025

    Price YTD change

    -24.75%
    NPCE price is down -24.75% since January 1st

    Price 1-year change

    +22.56%
    NPCE price is up +22.56% year-on-year

    Price 3-year change

    +71.49%
    NPCE price is up +71.49% over the past 3 years

    Price Range

    Price All-time high

    $27.38
    NPCE price is currently -69.25% below its historical high of $27.38

    Price 3-year low

    $1.22
    NPCE price is currently +590.16% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $278.55M
    NPCE market capitalization is $278.55 million

    Market cap 3-year change

    +128.32%
    NPCE market capitalization is up +128.32% over the past 3 years

    Market cap All-time high

    $643.71M
    NPCE market capitalization is currently -56.73% below its historical high of $643.71 million

    Market cap sector rank

    56.22%
    NPCE market capitalization is higher than 56.22% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13.3%
    NPCE shares outstanding is up +13.3% year-on-year

    Shares Outstanding 3-Year Change

    +33.14%
    NPCE shares outstanding is up +33.14% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.05
    NPCE beta is 1.05

    200-day SMA

    $11.35
    NPCE price is currently -25.80% below its 200-day simple moving average

    50-day SMA

    $9.93
    NPCE price is currently -15.18% below its 50-day simple moving average

    RSI

    35.04
    NPCE 14-day relative strength index is 35.04

    Volume

    1.16
    NPCE 30-day relative volume is 1.16

    ATR

    $0.57
    NPCE average true range is $0.57

    10-day Historical Volatility

    41.29%
    NPCE 10-day historical volatility is 41.29%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $79.91M
    NPCE annual revenue is $79.91 million

    Revenue Analysts estimate

    $95.67M
    NPCE annual revenue is currently -16.48% lower than the consensus analysts' forecast

    Revenue 1-year change

    +22.14%
    NPCE annual revenue is up +22.14% year-on-year

    Revenue Sector rank

    66.64%
    NPCE annual revenue is higher than 66.64% of companies in Healthcare sector

    EPS

    EPS

    -$0.93
    NPCE annual earnings per share is -$0.93

    EPS Analysts estimate

    -$0.85
    NPCE annual earnings per share is currently +9.51% higher than the consensus analysts' forecast

    EPS 1-year change

    +26.77%
    NPCE annual earnings per share is up +26.77% year-on-year

    EPS Sector rank

    53.9%
    NPCE annual earnings per share is higher than 53.9% of companies in Healthcare sector

    Profit

    Gross profit

    $59.09M
    NPCE annual gross profit is $59.09 million

    Gross margin

    73.94%
    NPCE annual gross profit margin is 73.94%

    Operating profit

    -$21.67M
    NPCE annual operating income is -$21.67 million

    Operating margin

    -27.12%
    NPCE annual operating profit margin is -27.12%

    Net income

    -$27.14M
    NPCE annual net profit is -$27.14 million

    Net margin

    -33.97%
    NPCE annual net profit margin is -33.97%

    Expenses

    Total expenses

    $101.58M
    NPCE annual total expenses is $101.58 million

    Operating expenses

    $80.76M
    NPCE annual total operating expenses is $80.76 million

    Cost of goods sold

    $20.82M
    NPCE annual cost of goods sold is $20.82 million

    Selling, general & administrative expenses

    $57.10M
    NPCE annual SGA is $57.10 million

    Depreciation and amortization

    $1.77M
    NPCE annual depreciation & amortization is $1.77 million

    Interest expense

    $8.80M
    NPCE annual interest expense is $8.80 million

    Income tax

    $0.00
    NPCE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$18.34M
    NPCE annual earnings before interest & taxes is -$18.34 million

    EBITDA

    -$16.57M
    NPCE annual EBITDA is -$16.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $94.65M
    NPCE annual total assets is $94.65 million

    Non current assets

    $13.31M
    NPCE annual long term assets is $13.31 million

    Current assets

    $81.34M
    NPCE annual total current assets is $81.34 million

    Cash and cash equivalents

    $13.43M
    NPCE annual cash & cash equivalents is $13.43 million

    Accounts receivable

    $12.85M
    NPCE annual accounts receivable is $12.85 million

    Inventory

    $13.38M
    NPCE annual inventory is $13.38 million

    Liabilities

    Total liabilities

    $86.63M
    NPCE annual total liabilities is $86.63 million

    Long term liabilities

    $71.48M
    NPCE annual total long term liabilities is $71.48 million

    Current liabilities

    $15.16M
    NPCE annual total current liabilities is $15.16 million

    Accounts payable

    $2.95M
    NPCE annual accounts payable is $2.95 million

    Debt

    Total debt

    $73.34M
    NPCE annual total debt is $73.34 million

    Total debt 1-year change

    +1.3%
    NPCE annual total debt is up +1.3% year-on-year

    Long term debt

    $71.48M
    NPCE annual long term debt is $71.48 million

    Short term debt

    $1.86M
    NPCE annual short term debt is $1.86 million

    Equity & Capital

    Shareholders equity

    $8.01M
    NPCE annual stockholders equity is $8.01 million

    Book value

    $8.01M
    NPCE annual book value is $8.01 million

    Retained earnings

    -$530.95M
    NPCE annual retained earnings is -$530.95 million

    Working capital

    $66.18M
    NPCE annual working capital is $66.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$17.95M
    NPCE annual cash flow from operations is -$17.95 million

    Cash from operations 1-year change

    +8.89%
    NPCE annual cash flow from operations is up +8.89% year-on-year

    Cash from investing

    $8.99M
    NPCE annual cash flow from investing activities is $8.99 million

    Cash from investing 1-year change

    -60.94%
    NPCE annual cash flow from investing activities is down -60.94% year-on-year

    Cash from financing

    $4.33M
    NPCE annual cash flow from financing activities is $4.33 million

    Cash from financing 1-year change

    -46.76%
    NPCE annual cash flow from financing activities is down -46.76% year-on-year

    CAPEX

    CAPEX

    $306.00K
    NPCE annual capital expenditures is $306.00 thousand

    CAPEX 1-year change

    +76.88%
    NPCE annual capital expenditures is up +76.88% year-on-year

    Free Cash Flow

    Free cash flow

    -$18.25M
    NPCE annual free cash flow is -$18.25 million

    Free cash flow 1-year change

    +8.15%
    NPCE annual free cash flow is up +8.15% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    73.94%
    NPCE annual gross profit margin is 73.94%

    Operating margin

    -27.12%
    NPCE annual operating profit margin is -27.12%

    Net margin

    -33.97%
    NPCE annual net profit margin is -33.97%

    ROA & ROE

    ROA

    -26.83%
    NPCE annual return on assets is -26.83%

    ROE

    -189.35%
    NPCE annual return on equity is -189.35%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NPCE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NPCE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    14.33
    NPCE price to book ratio is 14.33

    PB ratio Sector rank

    93.18%
    NPCE price to book ratio is higher than 93.18% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.14
    NPCE price to sales ratio is 3.14

    PS ratio Sector rank

    48.28%
    NPCE price to sales ratio is higher than 48.28% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $216.41M
    NPCE enterprise value is $216.41 million

    Enterprise value Sector rank

    58.35%
    NPCE enterprise value is higher than 58.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -14.06
    NPCE EV/EBITDA is -14.06

    EV/EBITDA Sector rank

    8.6%
    NPCE EV/EBITDA is higher than 8.6% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.37
    NPCE annual current ratio is 5.37

    Quick ratio

    4.48
    NPCE annual quick ratio is 4.48

    Leverage

    Debt to equity

    7.43
    NPCE annual debt to equity ratio is 7.43

    Interest coverage ratio

    -2.08
    NPCE annual interest coverage ratio is -2.08

    Risk & Stability

    Piotroski F-Score

    -
    NPCE piotroski f-score value is unknown

    Altman Z-Score

    -4.88
    NPCE altman z-score is -4.88

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 Wells Fargo
    Overweight
    May 28, 25 HC Wainwright & Co.
    Buy
    May 14, 25 JP Morgan
    Overweight
    May 14, 25 Cantor Fitzgerald
    Overweight
    Mar 5, 25 Cantor Fitzgerald
    Overweight
    Jan 30, 25 Wells Fargo
    Overweight
    Jan 21, 25 UBS
    Buy
    Dec 17, 24 JP Morgan
    Overweight
    Nov 13, 24 Wells Fargo
    Overweight
    Aug 14, 24 Wells Fargo
    Overweight

    Institutional Ownership

    Screeners with NPCE included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for NeuroPace, Inc.?
    • Does NeuroPace, Inc. pay dividends?
    • What sector is NeuroPace, Inc. in?
    • What industry is NeuroPace, Inc. in?
    • What country is NeuroPace, Inc. based in?
    • When did NeuroPace, Inc. go public?
    • Is NeuroPace, Inc. in the S&P 500?
    • Is NeuroPace, Inc. in the NASDAQ 100?
    • Is NeuroPace, Inc. in the Dow Jones?
    • When was NeuroPace, Inc.'s last earnings report?
    • When does NeuroPace, Inc. report earnings?

    What is the ticker symbol for NeuroPace, Inc.?

    The ticker symbol for NeuroPace, Inc. is NASDAQ:NPCE

    Does NeuroPace, Inc. pay dividends?

    No, NeuroPace, Inc. does not pay dividends

    What sector is NeuroPace, Inc. in?

    NeuroPace, Inc. is in the Healthcare sector

    What industry is NeuroPace, Inc. in?

    NeuroPace, Inc. is in the Medical Devices industry

    What country is NeuroPace, Inc. based in?

    NeuroPace, Inc. is headquartered in United States

    When did NeuroPace, Inc. go public?

    NeuroPace, Inc.'s initial public offering (IPO) was on April 22, 2021

    Is NeuroPace, Inc. in the S&P 500?

    No, NeuroPace, Inc. is not included in the S&P 500 index

    Is NeuroPace, Inc. in the NASDAQ 100?

    No, NeuroPace, Inc. is not included in the NASDAQ 100 index

    Is NeuroPace, Inc. in the Dow Jones?

    No, NeuroPace, Inc. is not included in the Dow Jones index

    When was NeuroPace, Inc.'s last earnings report?

    NeuroPace, Inc.'s most recent earnings report was on August 12, 2025

    When does NeuroPace, Inc. report earnings?

    The next expected earnings date for NeuroPace, Inc. is November 11, 2025
    On this page